期刊文献+

N末端脑钠肽前体对慢性阻塞性肺疾病急性加重期合并左心衰的诊断价值 被引量:24

Diagnostic value of N-terminal-pro-brain natriuretic peptide for patients with acute exacerbation of chronic obstructive pulmonary disease complicated with left heart failure
下载PDF
导出
摘要 目的:探讨N末端脑钠肽前体(NT—proBNP)对慢性阻塞性肺疾病急性加重期(AECOPD)合并左心衰的诊断价值。方法:收集2014年3月至2015年2月期间,呼吸内科病房确诊或既往诊断为AECOPD的患者109例,根据心脏彩超及临床特点将患者分为左心衰组(A组,21例)及非左心衰组(B组,88例),探讨影响AECOPD患者血浆NT—proBNP升高的相关因素,以及NT-proBNP对AECOPD合并左心衰的诊断价值,并拟出排除及诊断截点。结果:重线性回归分析提示NT—proBNP与降钙素原PCT(卢=0.180,P=0.011)、肺动脉压PAP(β=0.333,P:0.000)呈正相关,与左室射血分数LVEF(β=-0.511,P=0.000)呈负相关,NT—proBNP的ROC曲线下面积(AUC)为0.959(95%CI:0.915~1.002,P=0.000).排除截点为794.6pg/mL(敏感性:90.5%,特异性:92%),诊断截点为1618pg/mL(敏感性:85.7%,特异性:97.7%)。结论:NT—proBNP可协助诊断AECOPD患者是否合并左心衰。除左心功能不全外,系统炎症、肺动脉高压状态也可能是影响AECOPD患者NT—proBNP升高的因素。 Objective To discuss the diagnostic value of N-terminal-pro-brain natriuretic peptide (NT- proBNP) for patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) complicated with left heart failure. Methods Patients with medical history of AECOPD, or are diagnosed as AECOPD from March 2014 to February 2015 were involved in the study. Based on echocardiography and clinic characteristics, the patients were divided into left heart failure group (group A) and non-left heart failure group (group B). Related factors of elevated NT-proBNP in AECOPD and the diagnostic value of NT-proBNP for patients with AECOPD complicated with left heart failure were analyzed, and exclusive and diagnostic cutoff were worked out. Results In this study, 109 AECOPD patients were collected, including 21 patients in group A and 88 patients in group B. Multivariate linear regression analysis indicated NT-proBNP was positively associated with PCT ([3= 0.180,P = 0.011) and PAP(β = 0.333,P = 0.000), and negatively with LVEF(β = -0.511 ,P = 0.000)and the area under the ROC curve(AUC) was 0.959 (95% confidence interval:0.915-1.002,P = 0.000). The exclusive cutoff was 794.6 pg/mL(sensitivity : 90.5%, specificity : 92% ), and the diagnostic cutoff 1 618 pg/mL ( sensitivity : 85.7% ,specificity: 97.7%). Conclusions NT-proBNP can help to diagnose whether AECPOD patients are complicated with left heart failure. Besides left heart dysfunction and the state of systemic inflammation, pulmonary hypertension may be the reasons for the elevated NT-proBNP in AECOPD patients.
出处 《实用医学杂志》 CAS 北大核心 2015年第19期3182-3185,共4页 The Journal of Practical Medicine
关键词 N末端脑钠肽前体 慢性阻塞性肺疾病急性加重期 左心衰 N-terminal-pro-brain natriuretie peptide acute exacerbation of chronic obstructive pulmonary disease left heart failure
  • 相关文献

参考文献11

  • 1Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2014)[EB/OL]. http://www.goldcopd.org/ Global Initiative for Chronic Obstructive Lung Disease.
  • 2中国心力衰竭诊断和治疗指南2014[J].中华心血管病杂志,2014,42(2):98-122. 被引量:4665
  • 3Kilbride HS, Stevens PE, Eaglestone G, et al. Accuracy of the MDRD (modification of diet in renal disease)study and CKD-EPI (CKD epidemiology collaboration) equations for estimation of GFR in the elderly [J]. Am J Kidney Dis, 2013, 61(1):57-66.
  • 4胡北,叶珩,孙诚,何楷然,曾红科.床边检测氨基末端脑钠肽前体对急性呼吸困难的鉴别诊断价值[J].实用医学杂志,2013,29(6):925-927. 被引量:10
  • 5陈令东,顾鹏.急诊室脑钠肽测定在呼吸困难鉴别诊断中的应用[J].实用医学杂志,2012,28(21):3568-3570. 被引量:18
  • 6McMurray J J, Adamopoulos S, Anker SD, et ",d. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaborationwith the Heart Failure Association (HFA) of the ESC [J]. Eur J Heart Fail, 2012, 14 ( 8 ) : 803-869.
  • 7Hannink JDC, Van Helvoort HAC, Dekhuijzen PNR, et al. Heart failure and COPD: partners in crime? [J]. Respirology, 2010, 15(6): 895-901.
  • 8Gariani K. Use of brain natriuretic peptide to detect pviously unknown left ventricular dysfunction in patients with acute exacerbation of chronic obstrnctive pulmonary disease [J]. Swiss Med Wkly, 2011, 141 : w13298.
  • 9Nakamura T, Suzuki T, Kawagoe Y, et al. Polymyxin Bimmobilized fiber hemoperfusion attenuates increased plasma atrial natriuretic peptide and brain natriuretic Peptide levels in patients with septic shock [J]. ASAIO J, 2008,54(2):210-213.
  • 10Nikinmaa M. "What is hypoxia? " [J].Acta Physiol (Oxf), 2013, 209( 1 ) : 1-4.

二级参考文献22

  • 1蔡洪流,方强.血浆B型利钠肽浓度对心力衰竭诊断及预后判断的作用[J].中华急诊医学杂志,2006,15(9):816-819. 被引量:23
  • 2Yandle T G. Biochemistry of natriuretic peptides [J]. J Intern Med, 1994,235(6) :561-571.
  • 3Eren N K, Ertas F, Ytiksek U, et al. Additive prognostic value of NT-proBNP over TIME risk score in intermediate- risk patients with acute coronary syndrome [J]. Turk Kardiyol Dem Ars, 2009,37(1) : 1-8.
  • 4Mitrovic V, Luss H, Nitsche K, et al. Effects of the renal natriuretic peptide urodilatin (ularitide) in patients with decompensated chronic heart failure: a double-blind, placebo- controlled, ascending-dose trial [J]. Am Heart J, 2005,150 (6) : 1239.
  • 5Mueller C, Breidthardt T, Laule Kilian K, et al. The integration of BNP and NT-proBNP into clinical medicine [J], Swiss Med Wkly, 2007,137(1-2) :4-12.
  • 6Bhattacharyya S, Toumpanakis C, Caplin M E, et al. Usefulness of N-terminal pro-brain natriuretic peptide as a biomarker of the presence of carcinoid heart disease [J]. Am J Cardiol, 2008, 102(7) :938-942.
  • 7Vogelsang T W, Jensen R J, Monrad A L, et al. Independent effects of both right and left ventricular function on plasma brain natriuretic peptide [J]. Eur J Heart Fail, 2007,9(9): 892-$96.
  • 8McCullough P A, Nowak R M, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study [J]. Circulation, 2002, 106(4): 416-422.
  • 9Gaggin H K, Mohammed A A, Bhardwaj A, et al. Heart Failure Outcomes and Benefits of NT-proBNP-Guided Management in the Elderly: Results From the Prospective, Randomized ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study [J]. J Card Fail, 2012,18 (8) : 626-634.
  • 10Fabbian F, De Giorgi A, Pala M, et al. Elevated NT-proBNP levels should be interpreted in elderly patients presenting with dyspnea [J]. Eur J Intern Med, 2011,22(1) : 108-111.

共引文献4686

同被引文献200

引证文献24

二级引证文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部